{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT04426968: Phase 2 Interventional Completed Hepatitis B, Chronic
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04448379: Phase 1 Interventional Unknown status Locally Advanced or Metastatic Non-Small Cell Lung Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04393298: Phase 1/Phase 2 Interventional Completed Advanced Solid Tumors
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02040844: Phase 3 Interventional Completed Cat Allergy
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02040844: Phase 3 Interventional Completed Cat Allergy
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:nisotirostide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT00790920: Phase 3 Interventional Completed Stroke
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:pertuzumab zuvotolimod [INN]
Source URL:
Class:
PROTEIN
